Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.220
-0.030 (-0.71%)
At close: Dec 5, 2025
21.26%
Market Cap1.49B
Revenue (ttm)100.00K
Net Income (ttm)-58.91M
Shares Out352.99M
EPS (ttm)-0.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,510,228
Average Volume2,081,488
Open4.255
Previous Close4.250
Day's Range4.200 - 4.290
52-Week Range1.804 - 4.800
Beta0.08
RSI60.20
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.